Registered Nurse in Hawthorne, NV Accepting Medicare
3 Registered Nurse nurses found. Showing 1 - 3
 Mrs. Tamiya June Ferguson, RN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 331 1st Street, Hawthorne, NV 89415 Phone: 775-945-3657 Fax: 775-945-2039 |
Wanda Nixon, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 331 First Street, Hawthorne, NV 89415 Phone: 775-945-3657 |
Marilyn Dansesreau, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1000 C St, Hawthorne, NV 89415 Phone: 775-945-3368 Fax: 775-945-2307 |
News Archive
Waters exhibits the SYNAPT G2 system at the 18th International Mass Spectrometry Conference in Europe
Waters Corporation (NYSE: WAT) today exhibited for the first time in Europe the Waters((R)) SYNAPT(TM) G2 a system offering scientists greater power, versatility and speed at the 18(th) International Mass Spectrometry Conference (IMSC). Rounding out its display of mass spectrometry (MS) and UltraPerformance Liquid Chromatography (UPLC((R)))/MS systems at IMSC will be Waters Xevo(TM) family of tandem quadrupole and time-of-flight mass spectrometers noted for their ease-of-use and versatility.
‘City slickers' at increased brain stress: Study
German and Canadian neuroscientists have shown that living in a city or even being raised in one is associated with differences in the way the brain handles stress. They write in Nature that this is the first time researchers have used functional magnetic resonance imaging (fMRI) to identify specific brain regions that are affected by urban life.
Research: Gene behind epilepsy syndrome could play a key role in other idiopathic epilepsies
Researchers at the University Department of Neurology at the MedUni Vienna have identified a gene behind an epilepsy syndrome, which could also play an important role in other idiopathic (genetically caused) epilepsies.
Mystic awarded $245,000 QTDP grant for VersiDoser Delivery Platform
Mystic Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of advanced precision ophthalmic and intranasal delivery technologies for drugs and biologics, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to its VersiDoser™ Delivery Platform under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.
› Verified 5 days ago